HIV Research Division
Kenya Medical Research Institute (KEMRI) in collaboration with Centers for Disease Control & Prevention (CDC) established the HIV Research Division (HIVR) in 2001 to spearhead HIV prevention and treatment research within the Nyanza Region in Kenya, an area with the greatest burden of HIV/AIDS in the country.
The HIVR Division is housed at KEMRI’s Centre for Global Health Research (CGHR) in Kisumu County.
To perform high impact HIV prevention, treatment and health systems research with domestic and global relevance.
To be a leading Centre for HIV research aimed towards eliminating HIV infection.
In line with KEMRI’s mission of improving human health and quality of life through research, capacity building, innovation and service delivery; the HIVR Division conducts research related to epidemiology, prevention, management and treatment of HIV and associated conditions. This includes (but not limited to) HIV and other sexually transmitted infections; Tuberculosis and other opportunistic infections; non-communicable diseases affecting HIV-infected individuals; nutritional, genetic and metabolic conditions of importance in HIV treatment or prevention; structural, mental and behavioral factors affecting HIV pathogenesis, treatment and prevention; and other conditions affecting HIV-infected or at risk individuals.
It also conducts research on health systems and incorporates economic evaluation research, such as Point-of-Care (POC) and use of other novel testing devices, as well as promising practices designed to improve linkage to and engagement in patient and population-based care
Dr. Victor Mudhune
Division Staff Members
- Boaz Oyaro
- Evans Odipo Odhiambo
- Francis K.M. Angira
- Dr. Grace Mboya
- Ken Ondeng’e
- Philister Adhiambo Madiega
- Richard Ndivo
- Dr. Samuel Ouma
- Dr. Valarie Opollo